These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7858155

  • 1. Inhibitory effect of bombesin/gastrin-releasing peptide (GRP) antagonists RC-3950-II and RC-3095 on MCF-7 MIII human breast cancer xenografts in nude mice.
    Shirahige Y, Cai RZ, Szepeshazi K, Halmos G, Pinski J, Groot K, Schally AV.
    Biomed Pharmacother; 1994; 48(10):465-72. PubMed ID: 7858155
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice.
    Yano T, Pinski J, Szepeshazi K, Halmos G, Radulovic S, Groot K, Schally AV.
    Cancer; 1994 Feb 15; 73(4):1229-38. PubMed ID: 8313327
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095.
    Miyazaki M, Lamharzi N, Schally AV, Halmos G, Szepeshazi K, Groot K, Cai RZ.
    Eur J Cancer; 1998 Apr 15; 34(5):710-7. PubMed ID: 9713279
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of growth of MDA-MB-468 estrogen-independent human breast carcinoma by bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II.
    Kahán Z, Sun B, Schally AV, Arencibia JM, Cai RZ, Groot K, Halmos G.
    Cancer; 2000 Mar 15; 88(6):1384-92. PubMed ID: 10717621
    [Abstract] [Full Text] [Related]

  • 5. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K, Cai RZ.
    Br J Cancer; 1994 Nov 15; 70(5):886-92. PubMed ID: 7947094
    [Abstract] [Full Text] [Related]

  • 6. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice.
    Jungwirth A, Galvan G, Pinski J, Halmos G, Szepeshazi K, Cai RZ, Groot K, Schally AV.
    Prostate; 1997 Aug 01; 32(3):164-72. PubMed ID: 9254895
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of antagonists of bombesin/gastrin releasing peptide (GRP) and somatostatin analog (RC-160) on growth of HT-29 human colon cancers in nude mice.
    Radulovic S, Schally AV, Reile H, Halmos G, Szepeshazi K, Groot K, Milovanovic S, Miller G, Yano T.
    Acta Oncol; 1994 Aug 01; 33(6):693-701. PubMed ID: 7946450
    [Abstract] [Full Text] [Related]

  • 8. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
    Halmos G, Schally AV.
    Proc Natl Acad Sci U S A; 1997 Feb 04; 94(3):956-60. PubMed ID: 9023364
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
    Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T, Schally AV.
    Int J Cancer; 1994 May 15; 57(4):574-80. PubMed ID: 7910153
    [Abstract] [Full Text] [Related]

  • 10. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095.
    Szepeshazi K, Schally AV, Halmos G, Groot K, Radulovic S.
    J Natl Cancer Inst; 1992 Dec 16; 84(24):1915-22. PubMed ID: 1460673
    [Abstract] [Full Text] [Related]

  • 11. Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma.
    Koppán M, Halmos G, Arencibia JM, Lamharzi N, Schally AV.
    Cancer; 1998 Oct 01; 83(7):1335-43. PubMed ID: 9762934
    [Abstract] [Full Text] [Related]

  • 12. Bombesin antagonists inhibit in vitro and in vivo growth of human gastric cancer and binding of bombesin to its receptors.
    Qin Y, Halmos G, Cai RZ, Szoke B, Ertl T, Schally AV.
    J Cancer Res Clin Oncol; 1994 Oct 01; 120(9):519-28. PubMed ID: 8045917
    [Abstract] [Full Text] [Related]

  • 13. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
    Pinski J, Schally AV, Halmos G, Szepeshazi K.
    Int J Cancer; 1993 Dec 02; 55(6):963-7. PubMed ID: 7902829
    [Abstract] [Full Text] [Related]

  • 14. Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes.
    Bajo AM, Schally AV, Krupa M, Hebert F, Groot K, Szepeshazi K.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3836-41. PubMed ID: 11891317
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
    Plonowski A, Schally AV, Varga JL, Rekasi Z, Hebert F, Halmos G, Groot K.
    Prostate; 2000 Jul 01; 44(2):172-80. PubMed ID: 10881027
    [Abstract] [Full Text] [Related]

  • 16. Effect of bombesin, gastrin-releasing peptide (GRP)(14-27) and bombesin/GRP receptor antagonist RC-3095 on growth of nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K, Schally AV, Groot K, Halmos G.
    Int J Cancer; 1993 May 08; 54(2):282-9. PubMed ID: 8387464
    [Abstract] [Full Text] [Related]

  • 17. Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
    Rick FG, Buchholz S, Schally AV, Szalontay L, Krishan A, Datz C, Stadlmayr A, Aigner E, Perez R, Seitz S, Block NL, Hohla F.
    Cell Cycle; 2012 Jul 01; 11(13):2518-25. PubMed ID: 22751419
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
    Radulovic S, Miller G, Schally AV.
    Cancer Res; 1991 Nov 01; 51(21):6006-9. PubMed ID: 1682040
    [Abstract] [Full Text] [Related]

  • 19. Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP.
    Qin Y, Ertl T, Cai RZ, Horvàth JE, Groot K, Schally AV.
    Int J Cancer; 1995 Oct 09; 63(2):257-62. PubMed ID: 7591214
    [Abstract] [Full Text] [Related]

  • 20. Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.
    Bajo AM, Schally AV, Groot K, Szepeshazi K.
    Br J Cancer; 2004 Jan 12; 90(1):245-52. PubMed ID: 14710236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.